[Conservative therapy of Crohn disease--reliable measures based on clinical studies].
Hartmann
F
F
Medizinische Klinik, St. Marienkrankenhaus, Frankfurt.
Plauth
M
M
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D019804:Mesalamine; D008795:Metronidazole / Q000009:adverse effects / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D008795:Metronidazole; D012460:Sulfasalazine; D019804:Mesalamine
Konservative Therapie des Morbus Crohn--Gesichertes aufgrund von klinischen Studien.